Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Sarepta Therapeutics, Inc. (SRPT) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $90.42 Metrics
OS: 88.0 M -132 % ROE
Market cap: $7.96 B -33 % ROIC
Net cash: $1.99 B $22.61 per share
EV: $5.97 B

 
TTM Valuation
EBITDA ($485) M
EBIT ($526) M
EPS ($5.95)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues843.8612.4455.9380.8301.0154.65.41.3
            Revenue growth37.8%34.3%19.7%26.5%94.7%2751.6%332.6%-87.2%
Cost of goods sold592.1288.4273.9352.234.27.40.10.0
Gross profit251.6324.0182.028.6266.8147.25.31.3
            Gross margin29.8%52.9%39.9%7.5%88.6%95.2%98.1%100.0%
Selling, general and administrative877.1873.2830.4734.1207.8122.783.775.0
Research and development877.1771.2722.3560.9401.8166.7188.3146.4
EBITA-535.5-357.0-455.4-531.5-342.8-45.6-266.7-220.2
            EBITA margin-63.5%-58.3%-99.9%-139.6%-113.9%-29.5%-4919.8%-17572.5%
Amortization of intangibles0.70.70.70.80.91.10.0 
EBIT-536.2-357.7-456.1-532.3-343.6-46.6-266.7-220.2
            EBIT margin-63.5%-58.4%-100.1%-139.8%-114.1%-30.2%-4920.3%-17572.5%
Pre-tax income-690.0-418.9-553.1-713.9-362.6-48.6-267.3-220.0
Income taxes13.5-0.21.11.2-0.72.10.00.0
            Tax rate 0.0%  0.2% 0.0%0.0%
Net income-703.5-418.8-554.1-715.1-361.9-50.7-267.3-220.0
            Net margin-83.4%-68.4%-121.6%-187.8%-120.2%-32.8%-4930.2%-17560.3%
 
Diluted EPS($8.03)($5.15)($7.11)($9.71)($5.46)($0.86)($5.49)($5.20)
Shares outstanding (diluted)87.681.378.073.666.358.848.742.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy